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Abstract
Background: Autistic spectrum disorder (ASD) is characterized by impaired language, communication and social skills, as
well as by repetitive and stereotypic patterns of behavior. Many autistic subjects display a dysregulation of the immune
system which is compatible with an unresolved viral infection with prenatal onset, potentially due to vertical viral
transmission. Recently, the xenotropic murine leukemia virus-related virus (XMRV) has been implicated in chronic fatigue
syndrome (CFS) and in prostate cancer by several, though not all studies.
Methodology/Principal Findings: We assessed whether XMRV or other murine leukemia virus (MLV)-related viruses
are involved in autistic disorder. Using nested PCR targeted to gag genomic sequences, we screened DNA samples from:
(i) peripheral blood of 102 ASD patients and 97 controls, (ii) post-mortem brain samples of 20 ASD patients and 17 sex-
and age-matched controls, (iii) semen samples of 11 fathers of ASD children, 25 infertile individuals and 7 fertile controls.
No XMRV gag DNA sequences were detected, whereas peripheral blood samples of 3/97 (3.1%) controls were positive
for MLV.
Conclusions|Significance: No MLV-related virus was detected in blood, brain, and semen samples of ASD patients or
fathers. Hence infection with XMRV or other MLV-related viruses is unlikely to contribute to autism pathogenesis.
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Introduction
Autism Spectrum Disorder (ASD) is a complex neurodevelop-
mental disorder, characterized by different levels of impairment in
social interaction and communication, as well as by stereotypies and
rigid patterns of behaviour [1]. Disease onset occurs prior to 3 years
ofageand its incidence iscurrentlyestimated at 1/150 livebirths[2–
3]. ASD is the most heritable neuropsychiatric disorder, yet very few
cases can be solely explained on the basis of de novo genetic mutations
or cytogenetic abnormalities [4]. Vertical viral transmission
represents a non-genetic mechanism compatible with high parent-
to-offspring transmission and with low rates of disease-specific
genetic abnormalities [5]. Clinically, many ASD patients display a
dysregulation of the immune system, potentially suggestive of a
prenatal-onset, unresolved viral infection [6–7]. Vertically transmit-
ted viruses should be found more frequently in the affected tissues of
autistic individuals compared to controls: based on this hypothesis
we initially assessed the prevalence of several neurotropic viruses in
post-mortem brains of autistic patients and controls, finding a
significant association between ASD and polyomavirus infection [8].
In the present study, we focus our attention on xenotropic murine
leukemia virus-related virus (XMRV) and other xenotropic murine
leukemia (MLV)-related viruses. These retroviruses indeed represent
good candidates for vertical viral transmission in autism, because of
their ability to integrate into the parental host genome and thus
undergo parent-to-child transmission. Furthermore, XMRV infec-
tion is currently a source of serious concern in the USA for its
possible link with chronic fatigue syndrome (CFS) [9].
Using nested PCR, XMRV and MLV gag genomic sequences
were sought in the following biological samples: (a) peripheral
blood mononuclear cells (PBMC) belonging to 102 ASD patients
and 97 controls, (b) post-mortem brains of 20 ASD patients and 17
sex- and age-matched controls, and (c) semen samples belonging to
11 fathers of ASD children, 25 infertile individuals and 7 fertile
controls. Our results do not support the frequent involvement of
XMRV or MLV-related viruses in autism pathogenesis.
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Patients and samples
All subjects, except for post-mortem brain donors, were
recruited in Italy and are ethnically Italian. The demographic
characteristics of these samples are summarized in Table 1.
Briefly, (a) PBMC were obtained drawing blood from ASD
patients diagnosed for any ASD (either Autistic Disorder, Asperger
Disorder, or Pervasive Developmental Disorder Not Otherwise
Specified) according to DSM-IV criteria [1], and clinically
assessed as described [10]. Controls were drawn as prescribed by
family practitioner for a broad range of physical complaints
unrelated to psychiatric disorders and among nursing and medical
students at University Campus Biomedico (Rome, Italy), as
described [10]; (b) frozen post-mortem brain tissues dissected from
the superior temporal gyrus (Brodmann Areas 41/42 or 22) were
obtained through the Autism Tissue Program from the NICHD
Brain & Tissue Bank (Baltimore, MD) and the Harvard Brain
Tissue Resource Center (Belmont, MA). These tissue samples
largely overlap with those employed in our previous studies [10],
as this neocortical region hosts well-documented structural and
functional abnormalities in autism [11]; (c) semen samples were
provided by outpatients who underwent andrological evaluation
for infertility at the Division of Endocrinology of Catholic
University of the Sacred Heart (U.C.S.C., Rome, Italy) upon
vibratory stimulation using Ferticare Clinic (Multicept, Frederiks-
berg, Denmark), according to the ethical guidelines approved by
the Institutional Review Boards (IRB) of Catholic University of the
Sacred Heart and University Campus Bio-Medico (U.C.B.M.).
Within 1 hour from collection, semen specimens were separated
into seminal fluid and three cellular fractions (mobile sperm cells,
sperm cells with hypomotility, and non-mobile cells including
immobile spermatozoa, immature forms, leukocytes and epithelial
cells) by centrifugation at 300 g for 30 minutes using IsoliteH
(IrvineScientific, Santa Ana, CA, USA); aliquots were stored at
280uC until DNA extraction. The consent forms signed by all
individuals involved in blood and semen collection, including
parents for their children, were approved by the Institutional
Review Board of University Campus Bio-Medico (U.C.B.M.).
Nested PCR and sequencing
DNA was recovered by phenol/chloroform extraction and
ethanol precipitation, following cell digestion with proteinase K at
55uC overnight. XMRV gag nested PCR was performed as
previously described [12] with the following modifications:
approximately 80 ng of genomic DNA in 25 ml final PCR reaction
volume were used as a template for the first round PCR; 40 cycles
were done for each round of amplification. In our hands, nested
PCR sensitivity was at 10 viral copies, as in previous reports [13].
Each PCR experiment included equal numbers of patients and
controls, as well as negative controls for the first and second round
PCRs; in order to minimize the risk of contaminations, positive
controls were PCR-amplified separately and run on the same
agarose for band size determination, as in our previous studies [8].
Appropriately-sized PCR products (413 bp) were sequenced, using
a CEQ8000 DNA sequencer (Beckman-Coulter, Fullerton, CA).
In order to exclude contaminations with mouse genomic DNA,
MLV positive samples were also assessed by a nested PCR
targeting mouse histone deacetylase 5 (Hdac5) and displaying the
same sensitivity as the nested PCR used to detect MLV.
Results
No MLV-related virus gag sequences were detected in 96 blood
samples and 20 post-mortem brains of ASD patients, as well as in
25 semen fractions belonging to 9 fathers of ASD children
(Table 1). Similarly, 17 control brains, and 85 semen fractions
from 7 fertile and 25 infertile controls (Table 1) were negative for
MLV-related gag sequences. Three out of 97 (3.1%) peripheral
blood samples from unaffected controls were positive (Figure 1).
The difference between ASD blood samples and unaffected
controls does not reach statistical significance (Fisher’s exact
P-value=0.25, n.s.). DNA sequencing and BLAST analysis
unveiled in 3 control blood samples viral gag gene sequences
Table 1. Demographic characteristics of the samples used in this study.
Sample type (N) Status (N) Mean age ± SD (year) Sex
ASD
1 (N=20) 15.469.5 M:F=15:5
Post-mortem brains (N=37)
Controls (N=17) 17.268.5 M:F=12:5
ASD (N=102) 10.265.4 M:F=83:19
PBMCs
2 (N=199)
Controls (N=97) 50.0615.7 M:F=45:52
mobile spermatozoa (N=8)
hypomobile spermatozoa (N=8) ASD fathers (N=9 43.469.5 -
non-mobile cells (N=9)
mobile spermatozoa (N=19)
Semen (N=110) hypomobile spermatozoa (N=20) Infertile (N=25) 35.166.1 -
non-mobile cells (N=25)
mobile spermatozoa (N=7)
hypomobile spermatozoa (N=7) Fertile (N=7) 33.863.5 -
non-mobile cells (N=7)
1ASD, Autistic Spectrum Disorder.
2PBMCs, Peripheral Blood Mononuclear Cell.
doi:10.1371/journal.pone.0016609.t001
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MLV on chromosome 8 (GenBank Acc number: AC163617 nt
85467–85880). No mouse genomic contamination was detected in
these three positive MLV control samples by nested PCR targeting
the mouse histone deacetylase 5 (Hdac5) gene.
Discussion
Our results show that infection with XMRV or other MLV-
related viruses, assessed both in the central nervous system and in
blood, is not associated with ASD nor is likely implicated in
vertical viral transmission through parental gametes. We thus
replicate and largely extend a recent study reporting no association
between XMRV infection and autistic disorder [14].
A search for viruses as primary etiological agents in autism is
well justified. Congenital infection with rubella or cytomegalovirus
(CMV) represents one of the best-documented environmental
factors significantly associated with ASD (for review see [15,16]).
The largest longitudinal study involving several hundred children
prenatally exposed to rubella virus estimates at 7.4% the rate of
autism in this group, much higher than ASD prevalence rates in
the general population; risk appears especially high if rubella
infection occurs during the first 8 weeks postconception [17–20].
Evidence linking prenatal CMV infection to autism is more cir-
cumstantial, but several case reports have been published [21–28].
Risk estimates are essentially based on a small cohort of 7 prenatally
Figure1.XMRVgagnested PCRon PBMC DNA,showing positive
samples in lane 5, 9 and 12. A=autistic, C=control, L=ladder
(100 bp GeneDirex), +=positive control, 2=negative control.
doi:10.1371/journal.pone.0016609.g001
Table 2. Studies on XMRV and/or MLV-related virus in several pathologies, by country of origin of the sample.
Ref. Country Pathology Tissue Patients Controls Virus
[12] USA Prostate cancer Prostate tissue 9/86 (10%) - XMRV
[9] USA CFS
1 PBMC
2 68/101(67%) 8/218(3.7%) XMRV
[32] USA Prostate cancer Prostate tissue 14/233 (6%) 2/101 (2%) XMRV
[33] USA CFS PBMC 32/37(86.5%) 3/44 (6.8%) MLV-related
[13] USA CFS PBMC 0/50 (0%) 0/97 (0%) -
[31] USA Prostate cancer Prostate tissue 32/144 (22%) - XMRV
[29] USA CFS, HIV, RA
3 PBMC 0/293 (0%) - -
[30] USA Prostate cancer Prostate tissue 0/800 (0%) - -
[14] USA ASD
4 PBMC 0/134 (0%) 0/204(0%) -
TOTAL USA
7 155/1878 13/664
(8.2%) (2%)
[14] Italy ASD PBMC 0/96 (0%) - -
[34] Netherlands CFS PBMC 0/32 (0%) 0/43 (0%) -
[35] UK CFS PBMC 0/186 (0%) - -
[36] Netherlands Prostate cancer Prostate tissue 3/74 (4%) - XMRV
[37] UK CFS PBMC 0/108 (0%) - -
[38] Germany Prostate cancer Prostate tissue 1/105 (1%) 1/70 (1.4%) XMRV
[39] Germany Prostate cancer Prostate tissue 0/589 (0%) - -
[40] China CFS PBMC, plasma 0/65 (0%) 0/85 (0%) -
[41] Netherlands HIV Seminal plasma 0/54 (0%) - -
[42] France ID
5 & others PBMC & others 0/62 (0%) 0/99 (0%) -
[43] Germany RTI
6 Resp.secretions 20/267(7.4%) 2/62 (3%) XMRV
[44] UK HIV and HCV PMBC, plasma 0/232 (0%) - -
TOTAL REST OF THE WORLD
7 24/1870 3/359
(1.3%) (0.8%)
Studies were based on nested PCR or real time PCR (genomic or RT-PCR).
1CFS, Chronic Fatigue Syndrome,
2PBMC, Peripheral Blood Mononuclear Cells,
3RA, Rheumatoid Arthritis,
4ASD, Autistic Spectrum Disorder,
5ID, Infiammatory Diseases,
6RTI, Respiratory Tract Infections.
7Patients vs controls - USA: x
2=30.49, df=1, P=3.35610
28; Rest of the world: x
2=0.504, df=1, P=0.477, n.s.
USA vs Rest of the World - patients: x
2=98.57, df=1, P=3.13610
223; controls: x
2=1.900, df=1, P=0.170, n.s.
doi:10.1371/journal.pone.0016609.t002
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(2/7=28.6%) [25].
XMRV represents an interesting candidate to potentially play
a role in autism pathogenesis. It was initially identified by PCR
in approximately 10% of prostate cancer patients [12]. It is
phylogenetically related to MLV-related viruses and displays about
90% sequence identity with MLV [12]. Recently, XMRV
infection has been strongly associated with CFS [9]. Attempts to
replicate these initial results in European and North-American
cohorts of prostate cancer and CFS patients have yielded
conflicting results. In general, the association between XMRV
infection and human disease appears stronger in the USA
compared to Europe (Table 2). However, also four US studies
are completely negative [13,14,29,30], accounting for about two
thirds of the total patient sample recruited in North America
(Table 2). The discrepancy between European and North
American studies could therefore reflect differences in PCR-based
assay sensitivity rather than real geographical differences in the
prevalence of infection by XMRV or other MLV-related viruses.
In this respect, it will be important to establish and validate
universal assays, as recently proposed by the National Institutes of
Health.
Our results, combined with those reported by Sutherfield et al
[14], render XMRV contributions to autism highly unlikely.
Nonetheless we cannot exclude that MLV-related viruses may play
a role in rare cases.
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